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Hereditary factor XI (FXI) deficiency is a mild bleeding dis-
order, rare in the general population but relatively com-
mon among Ashkenazi Jews. The human F11 gene com-
prises 15 exons, spanning over 23 kb of the long arm of 
chromosome 4 (4q35). Homozygotes or compound het-
erozygotes typically show severe FXI deficiency, whereas 
heterozygotes show partial or mild deficiency. However, 
the genotype-phenotype relationship is difficult to estab-
lish, even among individuals within the same family. We 
report on a female patient with a heterozygous variant in 
F11 and FXI deficiency (49 IU/dL), who suffers from menor-
rhagia since menarche and easy bruising. She experienced 
excessive bleeding during thyroidectomy and after a ce-
sarean section. Her younger sister, who carries the same 
heterozygous variant in F11 and has mild FXI deficiency 
(47 IU/dL), has menorrhagia without other bleeding diffi-
culties although she has undergone several surgeries. Their 
father, who carries the same missense variant, has not ex-
perienced any bleeding difficulties (but he has not under-
gone any surgeries either). The family study revealed that 
the A428C mutation was inherited from the father. This 
variant has not previously been described in the literature 
and is the first F11 variant described in the Croatian popu-
lation. Our study showed that even when family members 
have the same germline F11 variant, they still may expe-
rience phenotypic variability, making disease prognosis 
more complex.
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Hereditary factor XI (FXI) deficiency is a rare condition in 
the general population (with estimated prevalence 1 per 
million) but relatively common in Ashkenazi Jews (1). The 
human F11 gene consists of 15 exons and spans around 23 
kb (2). Homozygotes or compound heterozygous have se-
vere FXI deficiency (<15 IU/dL), while heterozygotes have 
partial or mild deficiency (20-70 IU/dL) (3). To date, 220 
pathogenic variants in the F11 gene have been reported, 
of which 57% are missense variants (4). However, it is dif-
ficult to determine the genotype-phenotype relationship, 
even among individuals from the same family, who despite 
having the same F11 variant have different bleeding phe-
notypes (5). Here, we present a case of a novel heterozy-
gous missense variant in F11 gene in a Croatian family.
CASE REPORT
One of the family members, a 27-year-old woman, first 
presented to our neurology clinic with upper limb weak-
ness, difficulties releasing her hand-grip, and occasional 
leg cramps. She experienced excessive bleeding during 
thyroidectomy at the age of 26. Following a prolonged 
bleeding after a cesarean section at the age of 28, she was 
referred to a hematologist, who confirmed decreased FXI 
activity (49 IU/dL; reference range 67-127 IU/dL). She and 
two of her three sisters suffer from menorrhagia since me-
narche. Neurological examination revealed positive myo-
tonic phenomenon in her hands, with no other neurologi-
cal signs. Electromyography showed myotonic discharges 
in the hand muscles. Brain magnetic resonance imaging 
was normal, as were laboratory investigations, creatine 
kinase, protein electrophoresis, and acid alpha-glucosi-
dase activity. Muscle biopsy was inconclusive, but she had 
bronchial spasm after inhalation anesthetic administra-
tion. Molecular genetic analysis excluded myotonic dys-
trophy type 1 and 2.
Clinical exome sequencing identified a mutation in CLCN1 
gene, and the diagnosis of dominant congenital myoto-
nia was established. Molecular genetic testing of her fam-
ily revealed that her father, mother, and two of her sisters 
had CLCN1 gene mutation. Her family history is positive for 
cramps, myotonic phenomenon, and muscle weakness in 
her father and her three sisters. Interestingly, a second mu-
tation was found in the gene for FXI. The father had the FXI 
mutation and one sister had a decreased FXI activity and 
the FXI mutation (Figure 1, Figure 2).
We performed clinical exome sequencing of the five 
probands (father, mother, and three sisters; one sister was 
not tested). An average of 30 million reads was generated 
per sample. Publicly available databases (dbSNP, 1000 Ge-
nomes Project, Database of Genomic Variants) were used 
to check for commonly known variants and exclude them 
from further analysis. A heterozygous missense variant c. 
428 A>C (p.Asp143Ala) in the F11 gene was selected as a 
potential disease-causing variant for the father and two 
daughters. In silico programs (MutationTaster, SIFT and 
Polyphen) confirmed that this variant was deleterious. The 
alignment of the three protein sequences showed that the 
novel F11 missense variant was located in an evolutionarily 
conserved region (Figure 3).
DISCUSSION
We identified a novel missense F11 variant in a Croatian 
family with FXI deficiency (father and two daughters). The 
family study revealed that the A428C mutation was inher-
ited from the father. The novel variant c.428A>C leads to a 
sequence change that results in amino acid substitution 
(p.Asp143Ala) in the F11 gene. This variant is not present in 
publicly available population databases. Missense variants 
in F11 gene are known to be pathogenic and comprise the 
majority of identified genetic variants (6). In silico programs 
indicated that this variant was damaging, while sequence 
alignment programs showed that the residue p.Asp143 
was phylogenetically conserved.
Heavy chain and the light chain of human FXI protein con-
tain four apple (Ap) domains and a catalytic domain. The 
F11 variant detected in this study is located in the Ap2 
domain, which plays a major role in forming a com-
FIGURE 1. Family pedigree. Square indicates male members, circle indicates 
female members. Open symbols indicate unaffected individuals, dot in the 
middle indicates carriers, filled symbols indicate affected individuals, the ar-
row indicates the proband, the question mark represents the family member 
who was not tested.
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plex with high molecular fibrinogen (7). In FXI-deficient in-
dividuals, pathogenic variants are rarest in the Ap2 domain 
when compared with the other three apple domains (4).
Our proband suffers from menorrhagia since menarche 
and easy bruising, while bleeding problems started during 
thyroidectomy and reappeared two years later after a ce-
sarean section. Further hematological investigations con-
firmed FXI deficiency (49 IU/dL). Her younger sister, who 
also carries the same heterozygous variant in F11 and has 
mild FXI deficiency (47 IU/dL), has menorrhagia without 
other bleeding difficulties. She underwent appendix 
removal, muscle biopsy, and scoliosis surgery without any 
bleeding incidents. The father, who carries the same mis-
sense variant, has not experienced any bleeding difficul-
ties (but he has not undergone any surgeries either). Our 
patients showed intrafamilial phenotype variability, which 
is consistent with previous findings (8). Bleeding and FXI 
levels show a weak correlation, and genotype-phenotype 
relationships have been difficult to define (9,10). This is also 
the case in our patients, since the younger sister with the 
same variant and slightly lower FXI level than our proband 
has only menorrhagia but has had no bleedings during or 
after surgeries.
FIGURE 3. The location of the missense variant detected in the father and two daughters. The mutation site was referred against F11 
or F11 homologue gene from Homo sapiens (P03951), Mus musculus (Q91y47), and Bos Taurus (Q5NTB3). The position of the missense 
mutation is marked by an arrow.
FIGURE 2. Medical history timeline.
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Postpartum hemorrhage occurs more frequently if the pa-
tient has a history of bleeding, so pregnant women with 
bleeding phenotype are administered FXI concentrate or 
fresh frozen plasma at delivery. Our proband experienced 
prolonged bleeding after the first cesarean section, so be-
fore the second cesarean section she received antifibrin-
olytic tranexamic acid and fresh frozen plasma during sur-
gery. The second cesarean section was without prolonged 
bleeding, but she experienced postpartum wound inflam-
mation followed by fever.
In conclusion, we identified a novel missense variant 
c.428A>C in the F11 gene in a father and two daughters. 
This is the first F11 variant described in the Croatian popu-
lation. According to available public databases and current 
literature, the variant has also not been reported in other 
populations. Our study showed that even when the same 
germline F11 variant is identified in a family, the patients 
still experience phenotypic variability, making the disease 
prognosis more complex.
Funding None.
Ethical approval Patients gave their written informed consent for the pub-
lication of data and images.
Declaration of authorship all authors conceived and designed the study; 
all authors acquired the data; KGJ, AB, and FB analyzed and interpreted the 
data; KGJ, AB, and FB drafted the manuscript; all authors critically revised 
the manuscript for important intellectual content; all authors gave approval 
of the version to be submitted; all authors agree to be accountable for all 
aspects of the work.
Competing interests All authors have completed the Unified Competing 
Interest form at www.icmje.org/coi_disclosure.pdf (available on request 
from the corresponding author) and declare: no support from any organi-
zation for the submitted work; no financial relationships with any organiza-
tions that might have an interest in the submitted work in the previous 3 
years; no other relationships or activities that could appear to have influ-
enced the submitted work.
References
1 Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency 
in Ashkenazi Jews in Israel. N Engl J Med. 1991;325:153-8. 
Medline:2052060 doi:10.1056/NEJM199107183250303
2 Mohammed BM, Matafonov A, Ivanov I, Sun MF, Cheng Q, 
Dickeson SK, et al. An update on factor XI structure and function. 
Thromb Res. 2018;161:94. Medline:29223926 doi:10.1016/j.
thromres.2017.10.008
3 Bolton-Maggs PH. Factor XI deficiency-resolving the enigma? 
Hematology (Am Soc Hematol Educ Program). 2009;97-105. 
Medline:20008187 doi:10.1182/asheducation-2009.1.97
4 F XI Deficiency Mutation Database. Available from: http://www.
factorxi.org/fullList.php. Accessed: February 27, 2020.
5 Bolton-Maggs PH, Young Wan-Yin B, McCraw AH, Slack J, Kernoff 
PB. Inheritance and bleeding in factor XI deficiency. Br J Haematol. 
1988;69:521. Medline:3408688 doi:10.1111/j.1365-2141.1988.
tb02409.x
6 Duga S, Salomon O. Congenital factor XI deficiency: an update. 
Semin Thromb Hemost. 2013;39:621-31. Medline:23929304 
doi:10.1055/s-0033-1353420
7  Castaman G, Giacomelli SH, Caccia S, Riccardi F, Rossetti G, Dragani 
A, et al. The spectrum of factor XI deficiency in Italy. Haemophilia. 
2014;20:106-13. Medline:24112640 doi:10.1111/hae.12257
8 Santoro C, Di Mauro R, Baldacci E, De Angelis F, Abbruzzese R, 
Barone F, et al. Bleeding phenotype and correlation with factor XI 
(FXI) activity in congenital FXI deficiency: results of a retrospective 
study from a single centre. Haemophilia. 2015;21:496-501. 
Medline:25623511 doi:10.1111/hae.12628
9 Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham 
EG. Definition of the bleeding tendency in factor XI-deficient 
kindreds–a clinical and laboratory study. Thromb Haemost. 
1995;73:194. Medline:7792729 doi:10.1055/s-0038-1653750
10 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. 
Comparison of bleeding tendency, factor XI coagulant activity, 
and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 
1985;65:719. Medline:3871646 doi:10.1182/blood.V65.3.719.719
